Pfizer: COVID-19 treatment shows promise against omicron variant January 18, 2022 Auto Bot Preclinical Research 0 The pharmaceutical company reports studies have demonstrated the main protease inhibitor of Paxlovid maintains in vitro efficiency against the variant.